MediPoint: Total Knee Replacement – North America Analysis and Market Forecasts
- Pages: 57
- Published: May 2017
- Report Code: GDME1385CFR
Total Knee Replacement (TKR) is a viable treatment option for patients whose knees have become excessively worn or degenerated due to osteoarthritis. The direct costs of nonsurgical management (including medication and physical therapy) of knee osteoarthritis, one of the most common joint injuries, pale in comparison to the indirect costs such as loss of earnings, disability payments, and reduced productivity. Additionally, there are other personal costs such as weight gain due to reduced activity level and risk of narcotic abuse due to pain management, which further magnify the burden associated with osteoarthritis. Modern TKR can be traced back to the 1970s, but since then research into implant and instrumentation design has greatly improved outcomes such that TKR now demonstrates long-term survivorship. The resultant increase in the numbers of TKR procedures puts financial stress on the healthcare system in the short term, as it remains more expensive than nonsurgical interventions. Therefore, there is a need to improve patient outcomes while reducing the economic burden of TKR.
This report focuses on the market outlook for TKR devices in North America (Canada, Mexico, and US). The analysis identifies the key unmet needs in the TKR market, discusses the major drivers and barriers of adoption, and provides an in-depth understanding of physicians’ perceptions and the future outlook for this market by segment and geography.
Key Questions Answered in This Report:
What is the current and future TKR market outlook in the developed and emerging markets? What trends are affecting the North American market?
Which are the key, high growth markets that TKR manufacturers should expand into?
What are the unmet needs with the current generation of TKR devices? How will emerging technologies fulfill these unmet needs?
What are the challenges and complications that have hindered widespread adoption?
With developing the next-generation of devices, what aspects of the technology are device manufacturers focused on optimizing? How will new entrants impact the TKR market?
Overview of recent key industry events and analysis of their market impact.
Annualized total market revenue, procedure trends, and market outlooks by segment and by region through 2023.
Key topics covered include strategic competitor assessment, market characterization, identification of unmet needs, reimbursement considerations, evaluating market access in each region covered in the report, and implications of the emerging technologies in the market.
Analysis of the current and future market competition in the global TKR market. Insightful review of industry drivers, barriers, and challenges.
Reasons to buy
The report will enable you to:
Develop and design your in-licensing and out-licensing strategies through a review of marketed products and technologies.
Develop business strategies by understanding the trends shaping and driving the video laparoscopes market.
Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the video laparoscopes market in the future.
Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
Track device sales in country-specific video laparoscopes market from 2014-2023.
Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
Smith & Nephew
Table of Contents
Table of Contents
1 About the Authors
1.1.1 Tobe Madu, MSc, Analyst, Medical Devices
2 Table of Contents
2.1 List of Tables
2.2 List of Figures
3 Executive Summary
3.1 Key Metrics
3.2 Market Dynamics
3.3 Key Players
3.4 Future Outlook
3.5 What Do Physicians Think?
4.2 Related Reports
4.3 Upcoming Related Reports
5 Market Outlook
5.1 Procedure Trends
5.2 Pricing Trends
5.3 Revenue Trends
5.4 Company Share Analysis
6 Market Insights
6.1 North America
7 Competitive Assessment
7.1.1 Computer Navigation Technologies
7.1.2 Robotic Technologies
7.1.3 Generic Implants to Address Cost Concerns
7.1.4 Advanced Materials
7.1.5 Emerging Countries
7.1.6 Augmented implants
7.2.1 Portfolio Assessment
7.2.2 Competitive Positioning
7.3 DePuy Synthes
7.3.1 Portfolio Assessment
7.3.2 Deal Analysis
7.3.3 Competitive Positioning
7.4.1 Portfolio Assessment
7.4.2 Competitive Positioning
7.5 Lima Corporate
7.5.1 Portfolio Assessment
7.5.2 Deal Analysis
7.5.3 Competitive Positioning
7.6.1 Portfolio Assessment
7.6.2 Competitive Positioning
7.7.1 Portfolio Assessment
7.7.2 Deal Analysis
7.7.3 Competitive Positioning
7.8 MicroPort Orthopedics
7.8.1 Portfolio Assessment
7.8.2 Competitive Positioning
7.9 Smith & Nephew
7.9.1 Portfolio Assessment
7.9.2 Deal Analysis
7.9.3 Competitive Positioning
7.10.1 Portfolio Assessment
7.10.2 Deal Analysis
7.10.3 Competitive Positioning
7.11 Waldemar Link
7.11.1 Portfolio Assessment
7.11.2 Competitive Positioning
7.12 Zimmer Biomet
7.12.1 Portfolio Assessment
7.12.2 Deal Analysis
7.12.3 Competitive Positioning
7.13 Other Players
8.3.3 Secondary Research
8.3.4 Forecasting Methodology
8.3.5 Primary Research Summary
8.4 About MediPoint
8.5 About GlobalData
8.6 Contact Us
List of Tables
Table 1: TKR Market, Key Metrics, 2016–2023
Table 2: North America TKR Procedure Volume Forecast, 2014–2023
Table 3: North America TKR Implant Average Selling Price ($) Forecast, 2014–2023
Table 4: North America TKR Market Revenue Forecast ($M), 2014–2023
Table 5: North America TKR Company Share Analysis, 20161
Table 6: Aesculap – Key Marketed Products Assessment
Table 7: Aesculap – Key Clinical Trials
Table 8: DePuy Synthes – Key Marketed Products Assessment
Table 9: DePuy Synthes – Key Clinical Trials
Table 10: Exactech – Key Marketed Products Assessment
Table 11: Exactech – Key Clinical Trials
Table 12: Lima Corporate – Key Marketed Products Assessment
Table 13: Lima Corporate – Key Clinical Trials
Table 14: Medacta – Key Marketed Products Assessment
Table 15: Medacta – Key Clinical Trials
Table 16: Medtronic – Key Marketed Products Assessment
Table 17: MicroPort – Key Marketed Products Assessment
Table 18: Microport – Key Clinical Trials
Table 19: Smith & Nephew – Key Marketed Products Assessment
Table 20: Smith & Nephew – Key Clinical Trials
Table 21: Stryker – Key Marketed Products Assessment
Table 22: Stryker – Key Clinical Trials
Table 23: Waldemar Link – Key Marketed Products Assessment
Table 24: Waldemar Link – Key Clinical Trials
Table 25: Zimmer Biomet – Key Marketed Products Assessment
Table 26: Zimmer Biomet – Key Clinical Trials
Table 27: Summary of Other Players in the TKR Market, 2016
List of Figures
Figure 1: North America TKR Market Share Comparison by Country, 2016 and 2023